Merck bought rights to develop a promising antiviral discovered at Emory University and will work with partners to advance candidate vaccines based on the technology behind Ebola and measles immunizations NEW YORK : Merck & Co.
moved to bolster the global fight against the coronavirus, unveiling development plans for a pill to the treat the infection and two vaccines to prevent it.
The US drugmaker bought rights to develop a promising antiviral discovered at Emory University and will work with partners to advance candidate vaccines based on the technology behind Ebola and measles immunizations, according to statements on Tuesday.